What share options does SFL CFO Aksel Olesen hold according to the Form 3?

Aksel Olesen holds several share option grants over SFL common shares with exercise prices from $4.25 to $10.28 and expirations between 2026 and 2031. Each grant represents a specified number of underlying common shares held directly as part of his compensation.

How do Aksel Olesen’s SFL share options vest and become exercisable?

The share options issued under SFL’s Share Option Scheme vest over three years in one-third annual installments. Each grant starts vesting on a specific initial date and continues over the next two years, and the options become exercisable as each portion vests.

SFL Corp (NYSE: SFL) CFO details option grants and share holdings in Form 3

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

SFL Corp Ltd. Chief Financial Officer Aksel Olesen filed an initial ownership report listing his equity interests in the company. The filing shows several tranches of share options over common shares with exercise prices ranging from $4.25 to $10.28, each expiring between 2026 and 2031. The options vest over three-year periods in equal annual installments and become exercisable upon vesting. Olesen also reports direct ownership of 3,501 common shares.

Insider Trade Summary

7 transactions reported

Mixed 7 txns

Insider Olesen Aksel

Role Chief Financial Officer

Type	Security	Shares	Price	Value
holding	Share options	--	--	--
holding	Share options	--	--	--
holding	Share options	--	--	--
holding	Share options	--	--	--
holding	Share options	--	--	--
holding	Share options	--	--	--
holding	Common shares	--	--	--

Holdings After Transaction: Share options — 80,000 shares (Direct); Common shares — 3,501 shares (Direct)

Footnotes (1)

The share options issued pursuant to the Issuer's Share Option Scheme vest over a three-year period in increments of 1/3 per annum with initial vesting on May 13, 2022 and subsequent vesting on May 13, 2023 and May 13, 2024. These share options become exercisable upon vesting. The share options issued pursuant to the Issuer's Share Option Scheme vest over a three-year period in increments of 1/3 per annum with initial vesting on February 15, 2023 and subsequent vesting on February 15, 2024 and February 15, 2025. These share options become exercisable upon vesting. The share options issued pursuant to the Issuer's Share Option Scheme vest over a three-year period in increments of 1/3 per annum with initial vesting on February 14, 2024 and subsequent vesting on February 14, 2025 and February 14, 2026. These share options become exercisable upon vesting. The share options issued pursuant to the Issuer's Share Option Scheme vest over a three-year period in increments of 1/3 per annum with initial vesting on February 13, 2025 and subsequent vesting on February 13, 2026 and February 13, 2027. These share options become exercisable upon vesting. The share options issued pursuant to the Issuer's Share Option Scheme vest over a three-year period in increments of 1/3 per annum with initial vesting on March 12, 2026 and subsequent vesting on March 12, 2027 and March 12, 2028. These share options become exercisable upon vesting. The share options issued pursuant to the Issuer's Share Option Scheme vest over a three-year period in increments of 1/3 per annum with initial vesting on February 19, 2027 and subsequent vesting on February 19, 2028 and February 19, 2029. These share options become exercisable upon vesting.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Understanding Insider Trading Forms →

03/18/2026 - 04:38 PM

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Olesen Aksel

(Last)

(First)

(Middle)

BRYGGEGATA 3

(Street)

OSLO

NO-0112

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
SFL Corp Ltd. [ SFL ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Financial Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common shares	3,501	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Share options	⁽¹⁾	05/13/2026	Common shares	80,000	$4.25	D
Share options	⁽²⁾	02/15/2027	Common shares	75,000	$4.67	D
Share options	⁽³⁾	02/14/2028	Common shares	75,000	$7.16	D
Share options	⁽⁴⁾	02/13/2029	Common shares	75,000	$9.81	D
Share options	⁽⁵⁾	03/12/2030	Common shares	70,000	$7.52	D
Share options	⁽⁶⁾	02/19/2031	Common shares	97,000	$10.28	D

Explanation of Responses:

1. The share options issued pursuant to the Issuer's Share Option Scheme vest over a three-year period in increments of 1/3 per annum with initial vesting on May 13, 2022 and subsequent vesting on May 13, 2023 and May 13, 2024. These share options become exercisable upon vesting.

2. The share options issued pursuant to the Issuer's Share Option Scheme vest over a three-year period in increments of 1/3 per annum with initial vesting on February 15, 2023 and subsequent vesting on February 15, 2024 and February 15, 2025. These share options become exercisable upon vesting.

3. The share options issued pursuant to the Issuer's Share Option Scheme vest over a three-year period in increments of 1/3 per annum with initial vesting on February 14, 2024 and subsequent vesting on February 14, 2025 and February 14, 2026. These share options become exercisable upon vesting.

4. The share options issued pursuant to the Issuer's Share Option Scheme vest over a three-year period in increments of 1/3 per annum with initial vesting on February 13, 2025 and subsequent vesting on February 13, 2026 and February 13, 2027. These share options become exercisable upon vesting.

5. The share options issued pursuant to the Issuer's Share Option Scheme vest over a three-year period in increments of 1/3 per annum with initial vesting on March 12, 2026 and subsequent vesting on March 12, 2027 and March 12, 2028. These share options become exercisable upon vesting.

6. The share options issued pursuant to the Issuer's Share Option Scheme vest over a three-year period in increments of 1/3 per annum with initial vesting on February 19, 2027 and subsequent vesting on February 19, 2028 and February 19, 2029. These share options become exercisable upon vesting.

	/s/ Aksel Olesen	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What does SFL (SFL Corp Ltd.) CFO Aksel Olesen report in this Form 3 filing?

CFO Aksel Olesen reports his existing equity holdings in SFL Corp Ltd., including multiple share option grants and 3,501 common shares. The options cover specified numbers of common shares with defined exercise prices and expiration dates, reflecting his long-term compensation structure.

How many SFL common shares does CFO Aksel Olesen directly own?

The Form 3 states that Aksel Olesen directly owns 3,501 SFL common shares. This common share position is reported separately from his share option grants and reflects his current direct equity stake in the company’s stock.

Does the SFL Form 3 show any insider buying or selling by Aksel Olesen?

The Form 3 is an initial ownership report and lists Aksel Olesen’s existing share options and common share holdings. It does not report open-market purchases or sales, focusing instead on his current equity-based compensation and direct share position.